Peer Review History
Original SubmissionJune 7, 2019 |
---|
PONE-D-19-16058 ViraMiner: deep learning on raw DNA sequences for identifying viral genomes in human samples PLOS ONE Dear Mr Tampuu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers and myself are convinced that the investigators’ report a until now poorly examined avenue to exploration of metagenomic datasets for the presence of viral sequences. I anticipate that improvements, along suggested lines, can be carried out without further review. We would appreciate receiving your revised manuscript by Aug 18 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Ulrich Melcher Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): Language improvements needed: , in occurrence order are listed here. Line 2 “reside in” better than “reside on”? Or maybe both (in and on) l. 10 delete “the” l. 14 word order better: “obtain directly” L.22 delete “percentage”? l.. 30 vague antecedent: “it” l. 57 “in” in place of “on” in description of the Figure Also line 80, line 290, 300, 305, 306 I would appreciate more explanation in a legend to Figure 1 how values for pattern branch and frequency branch are deduced.. Also: what is meant by “fully connected”? l. 58 I prefer “puts out” and elsewhere l. 80 number disagreement “these type”; also l. 309 “a…models’ l. 160 “We repeated out to…” ??? meaning not clear l. 183-4 needs articles; ‘the former, ‘the latter’. L. 210-211 is not clear. Rewrite l. 262-3 needs work l.318-321 is not clear to me Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a very well written manuscript with promising results of 19 human metagenomes, however, there are some items that I considered they need to be addressed before publication: Although the machine learning model shows promising results, it would be interesting to the reader to know which genome regions of the viruses were used by the trained model to identify the potential new viruses. Is there any bias towards coat protein, RNA dependent RNA polymerase or any other genes to determine the presence of the virus in the dataset? Can you include in the results what are the hallmark genes that were mostly found in the identified sequences? This would possibly require HMMER to be run using the unknown sequences of your 19 metagenomes after blastn. Why didn’t you try contig lengths larger than 300, for instance 1000, 5000, 10000? Would your model perform better with those contig lengths? The tool requires further validation with more data. I understand that you are using 19 metagenomes and using partitions/baselines to train, and the AUROC can be considered a good parameter to evaluate your model. However, it is imperative to certainly know what is in your metagenome to be able to validate the current technology. I’d suggest to generate simulated human metagenomes using taxon profiles similar to the ones that you used in the training model. I would suggest using NeSSM, ART, MetaSim for the simulations to determine how your trained model performs in completely new datasets. Per line comments: Line 40: Builds on top of the CNN architecture of Ren [25]. Line 101: Spell out AUROC as Area Under the Receiver Operating Characteristics the first time in the text. Line 185: You can say something like: “trained to identify viruses infecting prokaryotic organisms” Line 251: replace producing by produced. Reviewer #2: This article proposed a new machine learning approach for characterizing unknown metagenomics contigs. The approach using ANN with raw DNA sequences as inputs is unique and novel. The authors demonstrated that the proposed approach “viralMiner” performs better than random forests and kmer as baseline. The writing is excellent as well. Because of the novelty of the approach, I recommend the paper accepted after minor revision. Several minor areas can be imporved: 1. The AUC is 0.92, however, the real performance 0.9 accuracy and 0.32 recall is not as impressive. I believe these numbers are much worse than blast, so I recommend emphasize this in the abstract 2. The real strength of this approach is to detect “unknown” contigs which cannot be detected by blast. However the training test validation experiments did not evaluate anything that is “unknown”. Maybe the authors can hold out some viral classes in the training and test if the machine learning approach can detect “unknown” contigs? 3. A table could be added to show all training viral classes. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
ViraMiner: deep learning on raw DNA sequences for identifying viral genomes in human samples PONE-D-19-16058R1 Dear Dr. Tampuu, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Ulrich Melcher Academic Editor PLOS ONE Additional Editor Comments (optional): I apologize for the various delays and misunderstandings. As recognized during the first reading, the submission showed great promise, but also some language work. The current revision is much more comprehensible. I will leave it up to the authors to act on my suggestions for this version. Line 130 In here, we exemplify the use of ViraMiner a recommendation system. Better?: Herein, we exemplify the use of ViraMiner as a recommendation system. 152 because among our datasets largest number better?: because, among our datasets, the largest number l.174 In addition, we investigated if ViraMiner In addition, we investigated whether ViraMiner l. 236 number disagreement "The most important criteria that ViraMiner had to satisfy, however, were" OR use plural "Criterion" L. 416 add "the" In the results section |
Formally Accepted |
PONE-D-19-16058R1 ViraMiner: deep learning on raw DNA sequences for identifying viral genomes in human samples Dear Dr. Tampuu: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ulrich Melcher Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .